203 related articles for article (PubMed ID: 37563614)
1. Iron-based metal-organic framework co-loaded with buthionine sulfoximine and oxaliplatin for enhanced cancer chemo-ferrotherapy via sustainable glutathione elimination.
Rao Z; Xia Y; Jia Q; Zhu Y; Wang L; Liu G; Liu X; Yang P; Ning P; Zhang R; Zhang X; Qiao C; Wang Z
J Nanobiotechnology; 2023 Aug; 21(1):265. PubMed ID: 37563614
[TBL] [Abstract][Full Text] [Related]
2. Hypertoxic self-assembled peptide with dual functions of glutathione depletion and biosynthesis inhibition for selective tumor ferroptosis and pyroptosis.
Gao Y; Li Y; Cao H; Jia H; Wang D; Ren C; Wang Z; Yang C; Liu J
J Nanobiotechnology; 2022 Aug; 20(1):390. PubMed ID: 36045424
[TBL] [Abstract][Full Text] [Related]
3. Manganese porphyrin-based metal-organic framework for synergistic sonodynamic therapy and ferroptosis in hypoxic tumors.
Xu Q; Zhan G; Zhang Z; Yong T; Yang X; Gan L
Theranostics; 2021; 11(4):1937-1952. PubMed ID: 33408790
[TBL] [Abstract][Full Text] [Related]
4. Triggered All-Active Metal Organic Framework: Ferroptosis Machinery Contributes to the Apoptotic Photodynamic Antitumor Therapy.
Meng X; Deng J; Liu F; Guo T; Liu M; Dai P; Fan A; Wang Z; Zhao Y
Nano Lett; 2019 Nov; 19(11):7866-7876. PubMed ID: 31594301
[TBL] [Abstract][Full Text] [Related]
5. A MOF-Based Potent Ferroptosis Inducer for Enhanced Radiotherapy of Triple Negative Breast Cancer.
Zeng L; Ding S; Cao Y; Li C; Zhao B; Ma Z; Zhou J; Hu Y; Zhang X; Yang Y; Duan G; Bian XW; Tian G
ACS Nano; 2023 Jul; 17(14):13195-13210. PubMed ID: 37256771
[TBL] [Abstract][Full Text] [Related]
6. A Potent Strategy of Combinational Blow Toward Enhanced Cancer Chemo-Photodynamic Therapy via Sustainable GSH Elimination.
Yu J; Xiao H; Yang Z; Qiao C; Zhou B; Jia Q; Wang Z; Wang X; Zhang R; Yang Y; Wang Z; Li J
Small; 2022 Mar; 18(9):e2106100. PubMed ID: 34910845
[TBL] [Abstract][Full Text] [Related]
7. Cysteine preservation confers resistance to glutathione-depleted cells against ferroptosis via CDGSH iron sulphur domain-containing proteins (CISDs).
Homma T; Kobayashi S; Fujii J
Free Radic Res; 2020 Jun; 54(6):397-407. PubMed ID: 32605459
[TBL] [Abstract][Full Text] [Related]
8. Biodegradable zwitterionic polymer-cloaked defective metal-organic frameworks for ferroptosis-inducing cancer therapy.
Zhang M; Yao X; Xu J; Song J; Mai S; Zhu W; Zhang Y; Zhu L; Yang W
Int J Pharm; 2024 Apr; 655():124032. PubMed ID: 38521374
[TBL] [Abstract][Full Text] [Related]
9. Iron ion and sulfasalazine-loaded polydopamine nanoparticles for Fenton reaction and glutathione peroxidase 4 inactivation for enhanced cancer ferrotherapy.
Zhu X; Chen Q; Xie L; Chen W; Jiang Y; Song E; Song Y
Acta Biomater; 2022 Jun; 145():210-221. PubMed ID: 35470077
[TBL] [Abstract][Full Text] [Related]
10. An all-in-one biomimetic iron-small interfering RNA nanoplatform induces ferroptosis for cancer therapy.
Huang S; Le H; Hong G; Chen G; Zhang F; Lu L; Zhang X; Qiu Y; Wang Z; Zhang Q; Ouyang G; Shen J
Acta Biomater; 2022 Aug; 148():244-257. PubMed ID: 35709941
[TBL] [Abstract][Full Text] [Related]
11. Potent nanoreactor-mediated ferroptosis-based strategy for the reversal of cancer chemoresistance to Sorafenib.
Wang X; Zhao L; Wang C; Wang L; Wu H; Song X; Wang W; Xu H; Dong X
Acta Biomater; 2023 Mar; 159():237-246. PubMed ID: 36736851
[TBL] [Abstract][Full Text] [Related]
12. Redox Responsive Metal Organic Framework Nanoparticles Induces Ferroptosis for Cancer Therapy.
He H; Du L; Guo H; An Y; Lu L; Chen Y; Wang Y; Zhong H; Shen J; Wu J; Shuai X
Small; 2020 Aug; 16(33):e2001251. PubMed ID: 32677157
[TBL] [Abstract][Full Text] [Related]
13. Multifunctional Sr/Se co-doped ZIF-8 nanozyme for chemo/chemodynamic synergistic tumor therapy
Wu A; Han M; Ni Z; Li H; Chen Y; Yang Z; Feng Y; He Z; Zhen H; Wang X
Theranostics; 2024; 14(5):1939-1955. PubMed ID: 38505601
[No Abstract] [Full Text] [Related]
14. A Fe(III)-porphyrin-oxaliplatin(IV) nanoplatform for enhanced ferroptosis and combined therapy.
Hu X; Li R; Wu W; Fang K; Zhu Z; Wang Y; Zhou L; Chen M; Dong C; Shi S
J Control Release; 2022 Aug; 348():660-671. PubMed ID: 35716884
[TBL] [Abstract][Full Text] [Related]
15. Tumor microenvironments self-activated nanoscale metal-organic frameworks for ferroptosis based cancer chemodynamic/photothermal/chemo therapy.
Liang Y; Zhang L; Peng C; Zhang S; Chen S; Qian X; Luo W; Dan Q; Ren Y; Li Y; Zhao B
Acta Pharm Sin B; 2021 Oct; 11(10):3231-3243. PubMed ID: 34729312
[TBL] [Abstract][Full Text] [Related]
16. Iron (II)-based metal-organic framework nanozyme for boosting tumor ferroptosis through inhibiting DNA damage repair and system Xc
Xue P; Zhuang H; Bai T; Zeng X; Deng J; Shao S; Yan S
J Nanobiotechnology; 2024 May; 22(1):228. PubMed ID: 38715049
[TBL] [Abstract][Full Text] [Related]
17. pH-Sensitive Polymeric Vesicles for GOx/BSO Delivery and Synergetic Starvation-Ferroptosis Therapy of Tumor.
Luo Y; Yan P; Li X; Hou J; Wang Y; Zhou S
Biomacromolecules; 2021 Oct; 22(10):4383-4394. PubMed ID: 34533297
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of isothiocyanate-containing hybrid androgen receptor (AR) antagonist to downregulate AR and induce ferroptosis in GSH-Deficient prostate cancer cells.
Qin Z; Ou S; Xu L; Sorensen K; Zhang Y; Hu DP; Yang Z; Hu WY; Chen F; Prins GS
Chem Biol Drug Des; 2021 May; 97(5):1059-1078. PubMed ID: 33470049
[TBL] [Abstract][Full Text] [Related]
19. Multienzyme-like Reactivity Cooperatively Impairs Glutathione Peroxidase 4 and Ferroptosis Suppressor Protein 1 Pathways in Triple-Negative Breast Cancer for Sensitized Ferroptosis Therapy.
Li K; Lin C; Li M; Xu K; He Y; Mao Y; Lu L; Geng W; Li X; Luo Z; Cai K
ACS Nano; 2022 Feb; 16(2):2381-2398. PubMed ID: 35041395
[TBL] [Abstract][Full Text] [Related]
20. Parallel Lipid Peroxide Accumulation Strategy Based on Bimetal-Organic Frameworks for Enhanced Ferrotherapy.
Xin H; Wang F; Luo R; Lei J
Chemistry; 2021 Mar; 27(13):4307-4311. PubMed ID: 33377225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
